Japan’s Eisai still seeking accelerated U.S. review of Alzheimer’s drug
Eisai Co. on Friday said it still plans to seek an accelerated U.S. approval pathway for ...
Read moreEisai Co. on Friday said it still plans to seek an accelerated U.S. approval pathway for ...
Read moreCopyright © 2021 198 Japan News.
Copyright © 2021 198 Japan News.